首页> 外国专利> METHOD AND DEVICE FOR ASSISTING DIAGNOSIS OF EFFICACY OF METHOTREXATE IN PATIENT WITH RHEUMATOID ARTHRITIS

METHOD AND DEVICE FOR ASSISTING DIAGNOSIS OF EFFICACY OF METHOTREXATE IN PATIENT WITH RHEUMATOID ARTHRITIS

机译:诊断类风湿关节炎患者甲氨蝶呤疗效的方法和装置

摘要

PROBLEM TO BE SOLVED: To provide a method for assisting diagnosis of effectiveness of MTX in a rheumatoid arthritis patient by using a novel marker set of single base polymorphism (SNP) related to effectiveness of methotrexate (MTX).;SOLUTION: At least one of SNPs of at least one gene selected from FPGS gene, GGH gene and SLC19A1 gene, at least one of the SNPs of FMO2 gene, at least one of the SNPs of SLC28A3 gene, at least one of the SNPs of EPHX1 gene, and at least one of the SNPs of PPARG gene in a biological sample obtained from a rheumatoid arthritis patient are analyzed, and effectiveness of MTX in the patient is determined based on an analysis result.;SELECTED DRAWING: None;COPYRIGHT: (C)2017,JPO&INPIT
机译:解决的问题:通过使用与甲氨蝶呤(MTX)有效性相关的单碱基多态性(SNP)新型标记物组,提供一种辅助类风湿性关节炎患者MTX有效性诊断的方法。解决方案:选自FPGS基因,GGH基因和SLC19A1基因的至少一种基因的SNP,FMO2基因的至少一种SNP,SLC28A3基因的至少一种SNP,EPHX1基因的至少一种SNP和至少分析类风湿关节炎患者的生物样品中PPARG基因的SNP之一,并根据分析结果确定该患者对MTX的有效性。;部分提要:无;版权:(C)2017,JPO&INPIT

著录项

  • 公开/公告号EP3101142B1

    专利类型

  • 公开/公告日2018-12-05

    原文格式PDF

  • 申请/专利权人 SYSMEX CORPORATION;SHINKO MEDICAL CORPORATION;

    申请/专利号EP20160172768

  • 发明设计人 KUMAGAI SHUNICHI;

    申请日2016-06-03

  • 分类号C12Q1/6883;

  • 国家 EP

  • 入库时间 2022-08-21 12:27:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号